The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis of Randomised Studies
Journal
Journal of Clinical Medicine
Date Issued
January 31, 2022
DOI
10.3390/jcm11030768
Abstract
Fibrates have proven efficacy in cardiovascular risk reduction and are commonly used, in addition to statins, to control hypertriglyceridaemia. Their use is often limited due to reduction in glomerular filtration rate at treatment initiation. However, recent studies suggest benign changes in kidney function and improvement of proteinuria, an established early marker of microvascular disease and kidney disease progression. We summarize the evidence from existing trials and provide a summary of effects of fibrates, alone or in combination, on kidney disease progression and proteinuria.
File(s)![Thumbnail Image]()
Name
jcm-11-00768 (1).pdf
Size
915.95 KB
Format
Adobe PDF
Checksum (MD5)
5d94495d9d83078928bad388754e6ef3